Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Tranexamic acid and oral retinoids may effectively treat lichen plan pigmentosus.

A man developed skin issues from cancer medication, which improved with specific treatments.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.